{"wiki_id": "http://www.wikidata.org/entity/Q7154482", "itemLabel": "Paul Workman", "itemDescription": "biologist", "wikipedia_url": "https://en.wikipedia.org/wiki/Paul_Workman_(scientist)", "wikipedia_page": {"main": "Paul Workman,  (born 30 March 1952) is a British scientist noted for his work on the discovery and development of pharmaceutical agents in the field of oncology. He is President and CEO of The Institute of Cancer Research In London.\n\n", "link_mentions": [{"page": "Leeds School of Medicine", "response": ["*Paul Workman (scientist)"]}, {"page": "Beatson West of Scotland Cancer Centre", "response": ["*Professor Paul Workman, FRS"]}, {"page": "List of fellows of the Royal Society W, X, Y, Z", "response": ["|Paul Workman||29/04/2016||1952 \u2013"]}, {"page": "List of honorary graduates of the University of Leeds", "response": ["* Paul Workman (DSc)"]}, {"page": "Workington Academy", "response": ["* Prof Paul Workman FRS, biochemist, Chief Executive since 2014 of the Institute of Cancer Research"]}, {"page": "Laurence Pearl", "response": ["Pearl and his research team were awarded the 2013 Cancer Research UK Translational Cancer Research Prize along with the team of Paul Workman at the Institute of Cancer Research for their seminal work in developing the Hsp90 molecular chaperone as a new target for cancer therapy and for their role in development of the drug AUY922."]}, {"page": "Professor Paul Workman", "response": ["#REDIRECT Paul Workman (scientist)"]}, {"page": "Paul Workman (Professor)", "response": ["#REDIRECT Paul Workman (scientist)"]}, {"page": "List of fellows of the Royal Society elected in 2016", "response": ["thumb|Professor Paul Workman FRS, pharmacologist", "# Paul Workman"]}]}}